Assistant to CEO, Novartis International AG (2005–2006).Head Finance, Novartis Pharmaceutical Inc.Project Director, Novartis International AG (2008–2010).CFO, Chief Financial and Administration Officer, Novartis Schweiz AG (2010–2012).Head Group Business planning and Analysis, Novartis International AG (2012–2015).CFO, Alcon EMEA, division of Novartis (2015–2017). CFO, Sandoz, division of Novartis (2017–2021).Chief Financial Officer and Member of the Executive Committee, Lonza Group Ltd (2021).Member of the Board of Directors, Assura (since May 2023).Philippe holds a Master’s Degree in Industrial Management and Manufacturing and a Bachelor’s Degree in Computer Science from the Swiss Federal Institute of Technology (ETH), Zürich (CH), as well as an MBA from Cornell University’s Johnson School (US). Various positions in technical development and manufacturing at Serono ( now Merck Serono) (1998–2003)Ĭhief Financial Officer (CFO) and Member of the Executive Committee (since December 2021).Various positions in technical development and manufacturing at Novartis Pharmaceuticals & Sandoz, Novartis Group (2003–2009).Global Head of Quality for Biopharmaceutical, Novartis Pharmaceuticals (2009–2010).Head of Global Pharma Technical Operations & Biologics Quality Assurance, Novartis Pharmaceuticals (2010–2012).Head of Quality, Pharmaceutical Division & Member Pharmaceutical Executive Committee, Novartis Pharmaceuticals (2012–2015).Head of Quality and Compliance, Global Pharma Technical Operations, F.Head of Global Pharma Technical Operations & Member Pharma Executive Team, F.Pierre-Alain Ruffieux holds a doctorate in Biotechnology and a master’s degree in Chemical Engineering and Biotechnology from the Swiss Federal Institute of Technology (EPFL), Lausanne (CH). Chief Executive Officer (CEO) and Member of the Executive Committee (since November 2020)
0 Comments
Leave a Reply. |